Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 New cancer chemotherapy drugs in Europe.

× No keyword cloud information.

87 in total

1. Oral estramustine phosphate (NSC-89199) in the treatment of advanced (stage D) carcinoma of the prostate.

Authors: A Mittelman; S K Shukla; K Welvaart; G P Murphy
Journal: Cancer Chemother Rep Date: 1975 Jan-Feb

2. Interaction of oncodazole (R 17934), a new antitumoral drug, with rat brain tubulin.

Authors: J Hoebeke; G Van Nijen; M De Brabander
Journal: Biochem Biophys Res Commun Date: 1976-03-22 Impact factor: 3.575

3. The oncostatic and immunosuppressive action of new nitrosourea derivatives containing sugar radicals.

Authors: J L Imbach; J L Montero; A Moruzzi; B Serrou; E Chenu; M Hayat; G Mathe
Journal: Biomedicine Date: 1975-12-20

4. Optimum fractionation of the C3H mouse mammary carcinoma using x-rays, the hypoxic-cell radiosensitizer Ro-07-0582, or fast neutrons.

Authors: J F Fowler; P W Sheldon; J Denekamp; S B Field
Journal: Int J Radiat Oncol Biol Phys Date: 1976 Jul-Aug Impact factor: 7.038

5. The effects of R U7934 (NSC 238159), a new antimicrotubular substance, on the ultrastructure of neoplastic cells in vivo.

Authors: M De Brabander; G Geuens; R Van De Veire; F Thoneé; F Aerts; L Desplenter; J De Cree; M Borgers
Journal: Eur J Cancer Date: 1977-06 Impact factor: 9.162

6. Clinical results with estramustine phosphate (NSC-89199): a comparison of the intravenous and oral preparations.

Authors: T Nilsson; G JONSSON
Journal: Cancer Chemother Rep Date: 1975 Jan-Feb

7. Alkylating properties of phosphoramide mustard.

Authors: M Colvin; R B Brundrett; M N Kan; I Jardine; C Fenselau
Journal: Cancer Res Date: 1976-03 Impact factor: 12.701

8. Epipodophyllotoxin VP 16213 in treatment of acute leukaemias, haematosarcomas, and solid tumours.

Authors:
Journal: Br Med J Date: 1973-07-28

9. Clinical study of rubidazone (22 050 R.P.), a new daunorubicin-derived compound, in 170 patients with acute leukemias and other malignancies.

Authors: C Jacquillat; M Weil; M F Gemon-Auclerc; V Izrael; A Bussel; M Boiron; J Bernard
Journal: Cancer Date: 1976-02 Impact factor: 6.860

10. Metronidazole (Flagyl): characterization as a cytotoxic drug specific for hypoxic tumour cells.

Authors: J L Foster; P J Conroy; A J Searle; R L Willson
Journal: Br J Cancer Date: 1976-05 Impact factor: 7.640